What is the Share Price of Alivus Life Sciences Ltd?
- Answer Field
-
The share price of Alivus Life Sciences Ltd for NSE is ₹ 1023.9 and for BSE is ₹ 1018.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, ALIVUS LIFE SCIENCES LTD share price is currently at ₹ 1023.9, which is down by -9.69 from its previous closing. Today, the stock has fluctuated between ₹ 996.50 and ₹ 1034.10. Over the past year, ALIVUS LIFE SCIENCES LTD has achieved a return of 23.63 %. In the last month alone, the return has been -3.24 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 641.84 |
Operating Expense | 467.15 |
Net Profit | 136.96 |
Net Profit Margin (%) | 21.33 |
Earnings Per Share (EPS) | 11.18 |
EBITDA | 200.77 |
Effective Tax Rate (%) | 26.02 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 39.43 | 21.20 | 2.15 | 302.17 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 126.30 | 16.55 | 1.31 | 1330.83 | 92.25 / 184.95 |
CIPLA LTD | 1551.30 | 25.11 | 4.41 | 125285.64 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 289.65 | 24.00 | 2.93 | 852.47 | 145.00 / 449.00 |
GLAXOSMITHKLINE PHARMA LT | 2916.75 | 57.85 | 29.54 | 49411.50 | 1924.30 / 3147.45 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 39.43 | 23.75 | 6.70 | 302.17 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 672.50 | 39.42 | 6.52 | 1944.24 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8961.95 | 133.66 | 32.97 | 22404.88 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 126.30 | 16.40 | 1.29 | 1330.83 | 92.25 / 184.95 |
Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune. Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' dated 10 August 2018. A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited. The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.
The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs).
In 2001, Glenmark Pharmaceuticals established its API business. The first product registered with USFDA in 2003. The Company acquired Glaxo SmithKline's (GSK) API manufacturing plant in Ankleshwar, Gujarat in 2003. It established manufacturing plant at Kurkumbh, Maharashtra in 2002. In 2004, it commenced manufacturing at Mohol, Maharashtra. In 2013, the Company commenced manufacturing at Dahej, Gujarat. The Company increased its API manufacturing capabilities by enhancing the existing production capacities at Ankleshwar Dahej facilities in FY 2023, by an aggregate annual total installed capacity of 640 KL.
The Company expanded projects with additional 240 KL at Dahej in 2023. The brownfield expansion at Dahej for Oncology Plant was completed. Out of the 2 independent modules, one module commissioned 100%. 192 KL out of the 400 KL intermediate manufacturing block at Ankleshwar commissioned in 2023.
The Company came up with an IPO of 21,022,222 Equity Shares comprising a Fresh Issue of 14,722,222 Equity Shares and Offer for Sale of 6,300,000 Equity Shares aggregating to Rs 1513.6 Crores in August, 2021.
The share price of Alivus Life Sciences Ltd for NSE is ₹ 1023.9 and for BSE is ₹ 1018.
The market cap of Alivus Life Sciences Ltd for NSE is ₹ 1,23,90.90 Cr. and for BSE is ₹ 0.0 Cr. as of now.
The 52 Week High and Low of Alivus Life Sciences Ltd for NSE is ₹ 1335.10 and ₹ 743.85 and for BSE is ₹ 1335.00 and ₹ 743.60.
You can trade in Alivus Life Sciences Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 25.05%.
Alivus Life Sciences Ltd share price is for NSE ₹ 1023.9 & for BSE ₹ 1018 as on Apr 25 2025 11:15 AM.
The market cap of Alivus Life Sciences Ltd for NSE ₹ 1,23,90.90 & for BSE ₹ 0.0 as on Apr 25 2025 11:15 AM.
As on Apr 25 2025 11:15 AM the price-to-earnings (PE) ratio for Alivus Life Sciences Ltd share is 28.58.
As on Apr 25 2025 11:15 AM, the price-to-book (PB) ratio for Alivus Life Sciences Ltd share is 207.16.
You can trade in Alivus Life Sciences Ltd shares with Bajaj Broking by opening a demat account.
To buy Alivus Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Alivus Life Sciences Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found